Renoprotective effect of vinpocetine and cilostazol on glycerol induced renal  injury in male rats

Duaa Ahmed; Ghaith Ali Jasim

doi:10.32947/ajps.v22i4.947

Authors

Duaa Ahmed Forensic medcine
Ghaith Ali Jasim Department of pharmacology and toxicology, collage of pharmacy, Mustsnsiriyriah university, Iraq

DOI:

https://doi.org/10.32947/ajps.v22i4.947

Keywords:

acute kidney injury, PDE: Phosphodiestrase enzyme inhibitors

Abstract

Acute kidney injury (AKI) is characterized by a sudden loss of kidney function that is established by increased serum creatinine levels and decreased urinary output. AKI is one of a group of functional kidney conditions

known as acute kidney disease and disorders (AKD), which can vary in severity and self-limiting to severe and chronic. Adminstrations of glycerol generate significant elevation in serum urea and creatinine that’s mean occurance of functional abnormalities in the kidney. Vinpocetine drug has many pharmacological targets with multiple action, phosphodiesterase inhibiters-1(PDE-1) inhibitor, a voltage-gated sodium channel, and Inhibitory kinase B (IKK) are 3 main molecule targets of vinpocetine. PDE1 has been implicated in the regulation of vasoconstriction, vascular and cardiac structure remodeling, and neuro-transmission. Cilostazol, a phosphodiesterase (PDE) III inhibitors, that widely used for many cases such as reduces direct vascular injury via different mechanism, such as vasodilation and antiplatelet action, anti-inflammation and platelet-leukocyte interaction minimisation, and inhibition of vascular proliferation via up-regulation of hepatocyte growth factors. In present study, we looked at the effect and mechanism of the drugs vinpocetine and cilostazol in an animal model of glycerol-induced AKI. Experiment done during the 14-day trial, rats were divided into five groups: the control group received 2ml/kg normal saline; the induction group received 10ml/kg intramuscular glycerol injection; the vinpocetine group received 5mg/kg via gavage for 14 days and on day 7 given glycerol IM, the cilostazol group received 50mg/kg for 14 days and on day 7 given glycerol IM, and the combination group received half dose vinpocetine (2.5mg/kg) and cilostazol (25mg/kg). We discovered that the induction group had higher levels of urea and creatinine, as well as increased inflammation and oxidative stress, and that their renal tissue showed morphological changes typical of AKI, whereas the combination groups reduced glycerol induce acute renal damage. This revealed that vinpocetine and cilostazol can reinforce renal rat protection by reducing serum urea and creatinine and improving histopathological changes.

References

- Kanagasundaram, S., Ashley, C., Bhojani, S., Caldwell, A., Ellam, T., Kaur, A., ... & Ostermann, M. (2019). UK Renal Association Clinical Practice Guideline for Acute Kidney Injury (AKI).‏

- Zhao W., Li J., Li Y., ChenY., & Jin H. (2022). Preventive Effect of Collagen Peptides from Acaudina molpadioides on Acute Kidney Injury through Attenuation of Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity.2022.‏ DOI: https://doi.org/10.1155/2022/8186838

- He L., Wei Q., Liu J., Yi M., Liu Y., Liu H., ... & Dong Z. (2017). AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. Kidney international. 92(5): 1071-1083.‏ DOI: https://doi.org/10.1016/j.kint.2017.06.030

- Song J, Ding H, Fan HJ, Dong WL, Sun ZX, Hou SK. Canine model of crush syndrome established by a digital crush injury device platform. Int J Clin Exp Pathol. 2015 Jun 1;8(6):6117-25. PMID: 26261489; PMCID: PMC4525823.

- Korrapati M. C., Shaner B. E., & Schnellmann, R. G. (2012). Recovery from glycerol-induced acute kidney injury is accelerated by suramin. Journal of Pharmacology and Experimental Therapeutics. 341(1): 126-136.‏ DOI: https://doi.org/10.1124/jpet.111.190249

- Iglesias-Baena, I., Barranco-Medina S., Lázaro-Payo A., López-Jaramillo F. J., Sevilla F., & Lázaro J. J. (2010). Characterization of plant sulfiredoxin and role of sulphinic form of 2-Cys peroxiredoxin. Journal of Experimental Botany. 61(5): 1509-1521.‏ DOI: https://doi.org/10.1093/jxb/erq016

- Medina, A. E. (2010). Vinpocetine as a potent antiinflammatory agent. Proceedings of the National Academy of Sciences, 107(22): 9921-9922.‏ DOI: https://doi.org/10.1073/pnas.1005138107

- Elnfarawy, A. A., Nashy A. E., Abozaid A. M., Komber, I. F., Elweshahy R. H., & Abdelrahman R. S. (2021). Vinpocetine attenuates thioacetamide-induced liver fibrosis in rats. Human & Experimental Toxicology. 40(2): 355-368.‏ DOI: https://doi.org/10.1177/0960327120947453

- Ono, K., & Tsuji, M. (2019). Pharmacological potential of cilostazol for Alzheimer’s disease. Frontiers in pharmacology. 10, 559.‏ DOI: https://doi.org/10.3389/fphar.2019.00559

- Kurtoglu T., Basoglu H., Ozkisacik E. A., Cetin N. K., Tataroglu C., Yenisey C., & Discigil B. (2014). Effects of cilostazol on oxidative stress, systemic cytokine release, and spinal cord injury in a rat model of transient aortic occlusion. Annals of vascular surgery. 28(2): 479-488.‏ DOI: https://doi.org/10.1016/j.avsg.2013.08.005

- Chancharoenthana W., Leelahavanichkul A., Taratummarat S., Wongphom J., Tiranathanagul K., & Eiam-Ong S. (2017). Cilostazol attenuates intimal hyperplasia in a mouse model of chronic kidney disease. PLoS One.12(12): e0187872.‏ DOI: https://doi.org/10.1371/journal.pone.0187872

- Nita M., & Grzybowski A. (2016). The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxidative medicine and cellular longevity. 2016.‏ DOI: https://doi.org/10.1155/2016/3164734

- Staiculescu M. C., Foote C., Meininger G. A., & Martinez-Lemus L. A. (2014). The role of reactive oxygen species in microvascular remodeling. International journal of molecular sciences. 15(12): 23792-23835.‏ DOI: https://doi.org/10.3390/ijms151223792

- Al Asmari A.K., Al Sadoon K.T., Obaid A.A. et al. Protective effect of quinacrine against glycerol-induced acute kidney injury in rats. BMC Nephrol 18. 41 (2017). DOI: https://doi.org/10.1186/s12882-017-0450-8

- Fattori V., Borghi S. M., Guazelli C. F., Giroldo A. C., Crespigio J., Bussmann A. J., ... & Verri Jr W. A. (2017). Vinpocetine reduces diclofenac-induced acute kidney injury through inhibition of oxidative stress, apoptosis, cytokine production, and NF-κB activation in mice. Pharmacological research. 120: 10-22.‏ DOI: https://doi.org/10.1016/j.phrs.2016.12.039

- Gokce M., Yuzbasioglu M. F., Bulbuloglu E. R. T. A. N., Oksuz H., Yormaz S., Altınoren O., ... & Kale I. T. (2012 July). Cilostazol and diltiazem attenuate cyclosporine-induced nephrotoxicity in rats. In Transplantation proceedings (Vol. 44, No. 6. Pp: 1738-1742). Elsevier.‏ DOI: https://doi.org/10.1016/j.transproceed.2012.04.025

- Song W., Yin W., Ding L., Gao Y., Xu J., Yang Y., ... & Zhang J. (2020). Vinpocetine reduces cisplatin-induced acute kidney injury through inhibition of NF–κB pathway and activation of Nrf2/ARE pathway in rats. International Urology and Nephrology.52(7):1389-1401.‏ DOI: https://doi.org/10.1007/s11255-020-02485-z

- Sancho-Martínez SM, López-Novoa JM, López-Hernández FJ. Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clin Kidney J. 2015 Oct;8(5):548-59. doi: 10.1093/ckj/sfv069. Epub 2015 Aug 25. PMID: 26413280; PMCID: PMC4581387. DOI: https://doi.org/10.1093/ckj/sfv069

- Hafez H. M., Ibrahim, M. A., Zedan M. Z., Hassan M., & Hassanein H. (2019). Nephroprotective effect of cilostazol and verapamil against thioacetamide-induced toxicity in rats may involve Nrf2/HO-1/NQO-1 signaling pathway. Toxicology Mechanisms and Methods. 29(2): 146-152.‏ DOI: https://doi.org/10.1080/15376516.2018.1528648